Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- 7-valent pneumococcal conjugate vaccine 1
- 13-valent pneumococcal conjugate vaccine 1
- 2019-nCoV Vaccine mRNA-1273 2
- 2019-nCoV Vaccine MRNA-1273 1
- Academic Medical Centers 1
- Adolescent 19
- Adult 22
- Aged 16
- Aged, 80 and over 4
- Age Distribution 1
- Age Factors 2
- Ambulatory Care Facilities 2
- Antibodies, Viral 2
- Antibodies, Viral/blood 1
- Antiviral Agents 1
- Article 2
- Asymptomatic Diseases 2
- Asymptomatic Infections 1
- bacteria 2
- BetacoronaVirus 5
- BNT162 Vaccine 3
- Brief Reports 1
- California 1
- Case-Control Studies 4
- Cerebral Palsy 1
- Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines 1
- Child 14
- Child, Preschool 15
- Chromosome Aberrations 1
- Clinical Laboratory Techniques 1
- Clinical Trials as Topic 1
- Coinfection 1
- Community-Acquired Infections 5
- Community-Acquired Infections/Transmission 1
- community-acquired pneumonia 3
- Contact Tracing 3
- CoronaVirus Infections 8
- Coronavirus Infections 1
- CoronaVirus Infections/Diagnosis 1
- CoronaVirus Infections/Prevention & Control 2
- CoronaVirus Infections/Prevention & cotrol 1
- CoronaVirus Infections/Transmission 1
- COVID-19 19
- COVID-19 Drug Treatment 1
- COVID-19 Serological Testing 1
- COVID-19 Vaccines 9
- COVID-19/Prevention & Control 2
- COVID-19/Prevention & cotrol 1
- Cross Infection 1
- Developmental Disabilities 1
- Dispatch 2
- Down Syndrome 1
- Emergency Service, Hospital 2
- Empyema, Pleural 1
- Environmental Exposure 1
- Family Characteristics 4
- Female 21
- Full Report 4
- Hospitalization 17
- Humans 34
- Immunocompromised Host 2
- Incidence 2
- Infant 8
- Infant, Newborn 3
- Influenza, Human 6
- Influenza A Virus, H1N1 Subtype 3
- Influenza Vaccines 4
- Length of Stay 2
- Logistic Models 2
- Male 22
- Middle Aged 20
- Mycoplasma pneumoniae 2
- Outpatients 2
- Pandemics 8
- Personnel, Hospital 2
- Pneumococcal Infections 2
- Pneumococcal Vaccines 3
- Pneumonia 3
- pneumonia 2
- Pneumonia, Viral 9
- Population Surveillance 4
- Prevalence 2
- Prospective Studies 4
- Research 2
- Respiration, Artificial 2
- Risk Assessment 2
- Risk Factors 2
- RNA, Messenger 2
- SARS-CoV-2 8
- Seasons 2
- Seroepidemiologic Studies 2
- Streptococcus pneumoniae 2
- Tennessee 3
- Time Factors 3
- United States 3
- Vaccination 8
- Vaccine Efficacy 5
- Vaccines, Combined 2
- Vaccines, Synthetic 3
- Young Adult 13
Personal Author
Corporate Author
- Baylor Scott & White Health. 4
- Baystate Medical Center, Springfield, Massachusetts 1
- Baystate Medical Center, Springfield, Massachusetts. 2
- Baystate Medical Center. 2
- Beth Israel Deaconess Medical Center. 3
- CDC COVID-19 Emergency Response Team. 1
- CDC COVID-19 Response Team 4
- CDC COVID-19 Response Team. 3
- CDC COVID- Response Team. 2
- Cleveland Clinic. 2
- Emory University School of Medicine. 2
- for the Centers for Disease Control and Prevention (CDC) Etiology of Pneumonia in the Community (EPIC) Study Team 1
- HAIVEN Investigators 1
- Harborview Medical Center (Seattle, Wash.) 1
- Hennepin County Medical Center. 5
- Hospitalized Adult Influenza Vaccine Effectiveness Network. 1
- Intermountain Health Care (Utah) 1
- Intermountain Medical Center (Utah) 1
- Intermountain Medical Center. 1
- Intermountain Medical Center and University of Utah, Salt Lake City, Utah 1
- Intermountain Medical Center and University of Utah. 1
- IVY Network 9
- IVY Network. 4
- IVY Network Investigators 3
- IVY Network Investigators. 1
- Johns Hopkins Hospital. 5
- Marshfield Clinic Research Institute. 1
- Montefiore Healthcare Center. 1
- Montefiore Medical Center. 1
- Montefiore Medical Center and Albert Einstein College of Medicine. 3
- National Center for Immunization and Respiratory Diseases (U.S.) 1
- Ohio State University. Wexner Medical Center. 2
- Ohio State University Wexner Medical Center. 2
- Oregon Health & Sciences University Hospital. 1
- Oregon Health & Science University Hospital. 3
- Ronald Reagan-UCLA Medical Center. 3
- St. Joseph Mercy Health System (Ann Arbor, Michigan) 1
- Stanford University. School of Medicine. 1
- Stanford University Medical Center. 1
- Stanford University School of Medicine. 1
- Texas A&M University. College of Medicine. 2
- Texas A&M University College of Medicine. 2
- UCLA Medical Center. 1
- University of Colorado School of Medicine (Aurora) 2
- University of Colorado School of Medicine, Aurora, Colorado 3
- University of Iowa. 3
- University of Miami. 2
- University of Michigan, School of Public Health. 1
- University of Michigan. School of Medicine. 1
- University of Michigan School of Medicine. 1
- University of Michigan School of Public Health. 3
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 1
- University of Utah. 1
- University of Washington School of Medicine. 3
- Vanderbilt University Medical Center, Nashville, Tennessee. 1
- Vanderbilt University Medical Center. 5
- Wake Forest University. Baptist Medical Center. 2
- Wake Forest University Baptist Medical Center. 3
- Washington University. 2
Place as Subject
- Alabama 1
- Arizona 1
- California 2
- Colorado 3
- Davidson County, TN 1
- Florida 1
- Georgia 1
- Germanu 1
- Indiana 1
- Iowa 1
- Los Angeles, CA 1
- Louisiana 1
- Maryland 3
- Massachusetts 2
- Michigan 1
- Minnesota 3
- Missouri 1
- New Mexico 1
- New York 2
- New York City, NY 1
- North Carolina 3
- Ohio 2
- Oregon 2
- Peru 1
- Seattle, WA 1
- Tennessee 11
- Texas 1
- United States 16
- Utah 4
- Washington 2
- Wisconsin 3
Resource Type General
Resource Type Specific
Keywords
- AAP recommendations 1
- acute respiratory illness 1
- Buprenorphine 1
- Catch up regimen 1
- Chlorination 1
- Conjugate vaccine 1
- coronavirus disease 1
- COVID-19 1
- COVID-19 Testing 1
- delivery of health care 1
- disease transmission 1
- epidemiology 1
- etiology 1
- health services research 1
- HIV 1
- household transmission 1
- Household water treatment 1
- Humans 1
- incidence 1
- influenza 1
- Influenza, Human 1
- Medicaid 1
- Methadone 1
- Mortality 1
- Naltrexone 1
- Nonvaccine serotypes 1
- Pandemics 1
- pandemics 1
- pediatric 1
- Pneumococcal disease 1
- pneumonia 1
- presenteeism 1
- respiratory infections 1
- Safe water storage 1
- SARS-CoV-2 2
- SARS-COV-2 1
- secondary infection risk 1
- severe acute respiratory syndrome coronavirus 2 1
- sexually transmitted infections 1
- teleworking 1
- Treatment 1
- United States 1
- viral culture 1
- viruses 1
- workplaces 1
Select all docs (Max 200)
1 -
20 of 46 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 7-valent pneumococcal conjugate vaccine (1)
- 13-valent pneumococcal conjugate vaccine (1)
- 2019-nCoV Vaccine mRNA-1273 (2)
- 2019-nCoV Vaccine MRNA-1273 (1)
- Academic Medical Centers (1)
- Adolescent (19)
- Adult (22)
- Aged (16)
- Aged, 80 and over (4)
- Age Distribution (1)
- Age Factors (2)
- Ambulatory Care Facilities (2)
- Antibodies, Viral (2)
- Antibodies, Viral/blood (1)
- Antiviral Agents (1)
- Article (2)
- Asymptomatic Diseases (2)
- Asymptomatic Infections (1)
- bacteria (2)
- BetacoronaVirus (5)
- BNT162 Vaccine (3)
- Brief Reports (1)
- California (1)
- Case-Control Studies (4)
- Cerebral Palsy (1)
- Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines (1)
- Child (14)
- Child, Preschool (15)
- Chromosome Aberrations (1)
- Clinical Laboratory Techniques (1)
- Clinical Trials as Topic (1)
- Coinfection (1)
- Community-Acquired Infections (5)
- Community-Acquired Infections/Transmission (1)
- community-acquired pneumonia (3)
- Contact Tracing (3)
- CoronaVirus Infections (8)
- Coronavirus Infections (1)
- CoronaVirus Infections/Diagnosis (1)
- CoronaVirus Infections/Prevention & Control (2)
- CoronaVirus Infections/Prevention & cotrol (1)
- CoronaVirus Infections/Transmission (1)
- COVID-19 (19)
- COVID-19 Drug Treatment (1)
- COVID-19 Serological Testing (1)
- COVID-19 Vaccines (9)
- COVID-19/Prevention & Control (2)
- COVID-19/Prevention & cotrol (1)
- Cross Infection (1)
- Developmental Disabilities (1)
- Dispatch (2)
- Down Syndrome (1)
- Emergency Service, Hospital (2)
- Empyema, Pleural (1)
- Environmental Exposure (1)
- Family Characteristics (4)
- Female (21)
- Full Report (4)
- Hospitalization (17)
- Humans (34)
- Immunocompromised Host (2)
- Incidence (2)
- Infant (8)
- Infant, Newborn (3)
- Influenza, Human (6)
- Influenza A Virus, H1N1 Subtype (3)
- Influenza Vaccines (4)
- Length of Stay (2)
- Logistic Models (2)
- Male (22)
- Middle Aged (20)
- Mycoplasma pneumoniae (2)
- Outpatients (2)
- Pandemics (8)
- Personnel, Hospital (2)
- Pneumococcal Infections (2)
- Pneumococcal Vaccines (3)
- Pneumonia (3)
- pneumonia (2)
- Pneumonia, Viral (9)
- Population Surveillance (4)
- Prevalence (2)
- Prospective Studies (4)
- Research (2)
- Respiration, Artificial (2)
- Risk Assessment (2)
- Risk Factors (2)
- RNA, Messenger (2)
- SARS-CoV-2 (8)
- Seasons (2)
- Seroepidemiologic Studies (2)
- Streptococcus pneumoniae (2)
- Tennessee (3)
- Time Factors (3)
- United States (3)
- Vaccination (8)
- Vaccine Efficacy (5)
- Vaccines, Combined (2)
- Vaccines, Synthetic (3)
- Young Adult (13)
- Baylor Scott & White Health. (4)
- Baystate Medical Center, Springfield, Massachusetts (1)
- Baystate Medical Center, Springfield, Massachusetts. (2)
- Baystate Medical Center. (2)
- Beth Israel Deaconess Medical Center. (3)
- CDC COVID-19 Emergency Response Team. (1)
- CDC COVID-19 Response Team (4)
- CDC COVID-19 Response Team. (3)
- CDC COVID- Response Team. (2)
- Cleveland Clinic. (2)
- Emory University School of Medicine. (2)
- for the Centers for Disease Control and Prevention (CDC) Etiology of Pneumonia in the Community (EPIC) Study Team (1)
- HAIVEN Investigators (1)
- Harborview Medical Center (Seattle, Wash.) (1)
- Hennepin County Medical Center. (5)
- Hospitalized Adult Influenza Vaccine Effectiveness Network. (1)
- Intermountain Health Care (Utah) (1)
- Intermountain Medical Center (Utah) (1)
- Intermountain Medical Center. (1)
- Intermountain Medical Center and University of Utah, Salt Lake City, Utah (1)
- Intermountain Medical Center and University of Utah. (1)
- IVY Network (9)
- IVY Network. (4)
- IVY Network Investigators (3)
- IVY Network Investigators. (1)
- Johns Hopkins Hospital. (5)
- Marshfield Clinic Research Institute. (1)
- Montefiore Healthcare Center. (1)
- Montefiore Medical Center. (1)
- Montefiore Medical Center and Albert Einstein College of Medicine. (3)
- National Center for Immunization and Respiratory Diseases (U.S.) (1)
- Ohio State University. Wexner Medical Center. (2)
- Ohio State University Wexner Medical Center. (2)
- Oregon Health & Sciences University Hospital. (1)
- Oregon Health & Science University Hospital. (3)
- Ronald Reagan-UCLA Medical Center. (3)
- St. Joseph Mercy Health System (Ann Arbor, Michigan) (1)
- Stanford University. School of Medicine. (1)
- Stanford University Medical Center. (1)
- Stanford University School of Medicine. (1)
- Texas A&M University. College of Medicine. (2)
- Texas A&M University College of Medicine. (2)
- UCLA Medical Center. (1)
- University of Colorado School of Medicine (Aurora) (2)
- University of Colorado School of Medicine, Aurora, Colorado (3)
- University of Iowa. (3)
- University of Miami. (2)
- University of Michigan, School of Public Health. (1)
- University of Michigan. School of Medicine. (1)
- University of Michigan School of Medicine. (1)
- University of Michigan School of Public Health. (3)
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. (1)
- University of Utah. (1)
- University of Washington School of Medicine. (3)
- Vanderbilt University Medical Center, Nashville, Tennessee. (1)
- Vanderbilt University Medical Center. (5)
- Wake Forest University. Baptist Medical Center. (2)
- Wake Forest University Baptist Medical Center. (3)
- Washington University. (2)
- Alabama (1)
- Arizona (1)
- California (2)
- Colorado (3)
- Davidson County, TN (1)
- Florida (1)
- Georgia (1)
- Germanu (1)
- Indiana (1)
- Iowa (1)
- Los Angeles, CA (1)
- Louisiana (1)
- Maryland (3)
- Massachusetts (2)
- Michigan (1)
- Minnesota (3)
- Missouri (1)
- New Mexico (1)
- New York (2)
- New York City, NY (1)
- North Carolina (3)
- Ohio (2)
- Oregon (2)
- Peru (1)
- Seattle, WA (1)
- Tennessee (11)
- Texas (1)
- United States (16)
- Utah (4)
- Washington (2)
- Wisconsin (3)
- AAP recommendations (1)
- acute respiratory illness (1)
- Buprenorphine (1)
- Catch up regimen (1)
- Chlorination (1)
- Conjugate vaccine (1)
- coronavirus disease (1)
- COVID-19 (1)
- COVID-19 Testing (1)
- delivery of health care (1)
- disease transmission (1)
- epidemiology (1)
- etiology (1)
- health services research (1)
- HIV (1)
- household transmission (1)
- Household water treatment (1)
- Humans (1)
- incidence (1)
- influenza (1)
- Influenza, Human (1)
- Medicaid (1)
- Methadone (1)
- Mortality (1)
- Naltrexone (1)
- Nonvaccine serotypes (1)
- Pandemics (1)
- pandemics (1)
- pediatric (1)
- Pneumococcal disease (1)
- pneumonia (1)
- presenteeism (1)
- respiratory infections (1)
- Safe water storage (1)
- SARS-CoV-2 (2)
- SARS-COV-2 (1)
- secondary infection risk (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- sexually transmitted infections (1)
- teleworking (1)
- Treatment (1)
- United States (1)
- viral culture (1)
- viruses (1)
- workplaces (1)
- :Smithee, Ryan B. ;Markus, Tiffanie M.2020 Jan-Dec | Health Serv Res Manag Epidemiol. 2020; 7:Objectives:To evaluate the impact of International Classification of Disease, 10th revision, Clinical Modification (ICD-10-CM) implementation on pneum...
- :Pratt, Caroline Quinn ;Zhu, YuweiDecember 17 2018 | Influenza Other Respir Viruses. 13(2):208-212:Ninety-five adults enrolled in the Etiology of Pneumonia in the Community study with negative admission influenza polymerase chain reaction (PCR) test...
- :Grijalva, Carlos G. ;Zhu, YuweiNov 30 2010 | PLoS One. 5(11).:BackgroundThe optimal vaccination strategy to mitigate the impact of influenza epidemics is unclear. In 2005, a countywide school-based influenza vacc...
- :Diaz, Maureen H. ;Cross, Kristen E.Mar 30 2016 | Open Forum Infect Dis. 2016; 3(2).:Mycoplasma pneumoniae was detected in a number of patients with community-acquired pneumonia in a recent prospective study. To assess whether other pa...
- :Tomczyk, Sara ;Jain, SeemaJun 20 2017 | Open Forum Infect Dis. 2017; 4(2).:BackgroundCommunity-acquired pneumonia (CAP) 2007 guidelines from the Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) re...
- :Fisher, Kiva A. ;Olson, Samantha M.May 2021 | Influenza Other Respir Viruses. 15(3):345-351:BackgroundSymptoms of mild COVID‐19 illness are non‐specific and may persist for prolonged periods. Effects on quality of life of persistent poor ...
- :Ahmed, Faruque ;Nowalk, Mary Patricia12 2023 | Emerg Infect Dis. 2023; 29(12):2442-2450:Both SARS-CoV-2 and influenza virus can be transmitted by asymptomatic, presymptomatic, or symptomatic infected persons. We assessed effects on work a...
- :Griffin, Marie R. ;Zhu, Yuwei7 11 2013 | N Engl J Med. 369(2):155-163:BackgroundThe introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into the US childhood immunization schedule in 2000 has substantially red...
- :Jain, Seema ;Williams, Derek J.2 26 2015 | N Engl J Med. 372(9):835-845:BackgroundU.S. incidence estimates of pediatric community-acquired pneumonia hospitalizations based on prospective data collection are limited. Update...
- :Grijalva, Carlos G. ;Zhu, YuweiMay 26 2011 | Thorax. 66(8):663-668.:BACKGROUNDAlthough recent reports suggest the incidence of parapneumonic empyema increased in several regions of the United States, national trends in...
- :Grijalva, Carlos G. ;Zhu, YuweiOct 13 2015 | JAMA. 314(14):1488-1497:ImportanceFew studies have evaluated the relationship between influenza vaccination and pneumonia, a serious complication of influenza infection.Objec...
- :Self, Wesley H. ;Grijalva, Carlos G.May 2012 | Emerg Infect Dis. 18(5):863-865.:To determine the number of emergency department visits attributable to influenza A(H1N1)pdm09 in Davidson County, Tennessee, USA, we used active, popu...
- :Grijalva, Carlos G. ;Craig, Allen S.Jan 2006 | Emerg Infect Dis. 12(1):103-109.:Although influenza causes more hospitalizations and deaths among American children than any other vaccine-preventable disease, deriving accurate popul...
- :Fan, Roger R. ;Howard, Leigh M.Nov 2016 | Emerg Infect Dis. 22(11):1996-1999.:We examined nasopharyngeal pneumococcal colonization density patterns surrounding acute respiratory illnesses (ARI) in young children in Peru. Pneumoc...
- :Wiese, Andrew D. ;Grijalva, Carlos G.Jun 2016 | Emerg Infect Dis. 22(6):1109-1112.:Introduction of pneumococcal conjugate vaccines in the childhood immunization schedule was associated with decreases in all-cause pneumonia hospitaliz...
- :Lu, Xiaoyan ;Schneider, Eileen11 01 2017 | J Infect Dis. 216(9):1104-1111:BackgroundRhinoviruses (RVs) are ubiquitous respiratory pathogens that often cause mild or subclinical infections. Molecular detection of RVs from the...
- :Lessa, Fernanda C. ;Spiller, MichaelOctober 24, 2018 | ACIP meeting Pneumococcal Vaccines
- :Jules, Astride ;Grijalva, Carlos G.Feb 23 2012 | Influenza Other Respi Viruses. 2012; 6(3):e63-e71.:BackgroundIn April 2009, a pandemic caused by a novel influenza strain, the A(H1N1)pdm09 virus, started. Few age-specific estimates of hospitalization...
- :Lanier, Paul ;Kennedy, Susan6 2023 | South Med J. 116(6):455-463:Objectives:The purpose of this study was to measure sexually transmitted infection (STI) testing among Medicaid enrollees initiating preexposure proph...
- :Howard, Leigh M. ;Zhu, YuweiNovember 2019 | Emerg Infect Dis. 25(11):2040-2047:Increased nasopharyngeal pneumococcal (Streptococcus pneumoniae) colonization density has been associated with invasive pneumococcal disease, but fact...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.